Dr Monica Sharma

About

I manage various programs related to public health at BIRAC- GCI, New Delhi. Earlier, I have worked with Indian Council of Medical Research, New Delhi and PGIMER, Chandigarh. My research interests are in public health, infectious diseases, diagnostics, drug targets, and antimicrobial resistance.
I worked on the pathobiology of Streptococcus pneumoniae and its drug target during my doctoral research. I have undertaken field studies in the community to study the prevalence of Upper Respiratory Tract pathogens in children. I have an in-depth understanding of microbiology, molecular biology and immunology. I am skilled in surveillance and field studies, data analysis, and managing and coordinating research in public health.
I have received fellowships/grants/awards and trainings from ICMR, PGIMER, NIH, ISPPD, WOHC and LSHTM.

Employment

• Biotechnology Industry Research Assistance Council Senior Manager Programs
  2023 - Present
• Indian Council of Medical Research Scientist
  2017 - 2023
• Post Graduate Institute of Medical Education and Research Research Assistant
  2010 - 2011

Education

• Post Graduate Institute of Medical Education and Research Ph.D.
  2011 - 2016

Projects & Funding

Projects & funding information is unavailable.

Publications (11)

• Target product profiles for diagnosis of sepsis: Proposing a new approach for diagnostic innovation
  Indian Journal of Medical Research 2023 DOI: 10.4103/ijmr.ijmr_1936_22
  +Save
• Unmet needs for management of drug-resistant infections: low- and middle-income countries’ viewpoint
  Drug Target Insights 2022 DOI: 10.33393/dti.2022.2532
  +Save
• Antimicrobial Susceptibility Pattern and Serotype Distribution of Streptococcus pneumoniae Isolates From a Hospital-Based Study in Chandigarh, North India
  Cureus 2022 DOI: 10.7759/cureus.21437
  +Save
• Understanding complexities in the uptake of indigenously developed rapid point-of-care diagnostics for containment of antimicrobial resistance in India
  BMJ Global Health 2021 DOI: 10.1136/bmjgh-2021-006628
  +Save
• An integrated surveillance network for antimicrobial resistance, India
  Bulletin of the World Health Organization 2021 DOI: 10.2471/blt.20.284406
  +Save
• Targeting Streptococcus pneumoniae UDP-glucose pyrophosphorylase (UGPase): in vitro validation of a putative inhibitor
  Drug Target Insights 2020 DOI: 10.33393/dti.2020.2103
  +Save
• Understanding policy dilemmas around antibiotic use in food animals & offering potential solutions
  Indian Journal of Medical Research 2019 DOI: 10.4103/ijmr.ijmr_2_18
  +Save
• Inhibition of enteroaggregative Escherichia coli cell adhesion in-vitro by designed peptides
  Microbial Pathogenesis 2016 DOI: 10.1016/j.micpath.2016.06.014
  +Save
• Virulence determinants in enteroaggregativeEscherichia colifrom North India and their interaction inin vitroorgan culture system
  FEMS Microbiology Letters 2016 DOI: 10.1093/femsle/fnw189
  +Save
• Abstracts of 42nd National Conference of Association of Clinical Biochemists of India (ACBICON 2015)
  Indian Journal of Clinical Biochemistry 2015 DOI: 10.1007/s12291-015-0537-6
  +Save